secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0000950170-23-062492
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen names Kevin Smith President and CEO; new compensation includes $1.7M sign-on bonus
--------------------------------------------------------------------------------

- Kevin Smith appointed President and CEO effective Nov 10, 2023, succeeding Nabil Shabshab who departed same day.
- Smith brings over 20 years med-device leadership, most recently CEO of Sirtex Medical.
- Compensation: $700K salary, 100% target bonus, $1.7M sign-on bonus (two installments), 170K equity (RSUs + PSUs).
- Full-year 2023 financial guidance reaffirmed; company will skip Stifel and Piper Sandler conferences.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/0000950170-23-062492-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/ingn-20231110.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-062492

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer